These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10966753)

  • 1. Design, synthesis, and pharmacological characterization of 4-[4, 4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]- 2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand.
    Van Dort ME; Robins DM; Wayburn B
    J Med Chem; 2000 Aug; 43(17):3344-7. PubMed ID: 10966753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5285-8. PubMed ID: 15454212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1045-7. PubMed ID: 11327585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.
    Chen J; Hwang DJ; Chung K; Bohl CE; Fisher SJ; Miller DD; Dalton JT
    Endocrinology; 2005 Dec; 146(12):5444-54. PubMed ID: 16166218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7alpha-Iodo and 7alpha-fluoro steroids as androgen receptor-mediated imaging agents.
    Labaree DC; Hoyte RM; Nazareth LV; Weigel NL; Hochberg RB
    J Med Chem; 1999 Jun; 42(11):2021-34. PubMed ID: 10354410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.
    Yin D; He Y; Perera MA; Hong SS; Marhefka C; Stourman N; Kirkovsky L; Miller DD; Dalton JT
    Mol Pharmacol; 2003 Jan; 63(1):211-23. PubMed ID: 12488554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.
    He Y; Yin D; Perera M; Kirkovsky L; Stourman N; Li W; Dalton JT; Miller DD
    Eur J Med Chem; 2002 Aug; 37(8):619-34. PubMed ID: 12161060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
    Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
    Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.
    Kirkovsky L; Mukherjee A; Yin D; Dalton JT; Miller DD
    J Med Chem; 2000 Feb; 43(4):581-90. PubMed ID: 10691684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.
    Ostrowski J; Kuhns JE; Lupisella JA; Manfredi MC; Beehler BC; Krystek SR; Bi Y; Sun C; Seethala R; Golla R; Sleph PG; Fura A; An Y; Kish KF; Sack JS; Mookhtiar KA; Grover GJ; Hamann LG
    Endocrinology; 2007 Jan; 148(1):4-12. PubMed ID: 17008401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of nonsteroidal androgens.
    Dalton JT; Mukherjee A; Zhu Z; Kirkovsky L; Miller DD
    Biochem Biophys Res Commun; 1998 Mar; 244(1):1-4. PubMed ID: 9514878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacology of a nonsteroidal ligand for androgen receptor-mediated imaging of prostate cancer.
    Yang J; Bohl CE; Nair VA; Mustafa SM; Hong SS; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2006 Apr; 317(1):402-8. PubMed ID: 16434567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor.
    Teutsch G; Goubet F; Battmann T; Bonfils A; Bouchoux F; Cerede E; Gofflo D; Gaillard-Kelly M; Philibert D
    J Steroid Biochem Mol Biol; 1994 Jan; 48(1):111-9. PubMed ID: 8136296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
    Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK
    Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways.
    Narayanan R; Coss CC; Yepuru M; Kearbey JD; Miller DD; Dalton JT
    Mol Endocrinol; 2008 Nov; 22(11):2448-65. PubMed ID: 18801930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
    Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential radioiodinated ligand for androgen receptor: 7 alpha-methyl-17 alpha-(2'-(E)-iodovinyl)-19-nortestosterone.
    Salman M; Chamness GC
    J Med Chem; 1991 Mar; 34(3):1019-24. PubMed ID: 2002446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.
    Krishnan AV; Zhao XY; Swami S; Brive L; Peehl DM; Ely KR; Feldman D
    Endocrinology; 2002 May; 143(5):1889-900. PubMed ID: 11956172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques.
    Pan HJ; Wilding G; Uno H; Inui S; Goldsmith L; Messing E; Chang C
    Endocrine; 1998 Aug; 9(1):39-43. PubMed ID: 9798729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.